Skip to main content

Closed

VRDN: Viridian Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

27thpctl

Volume

0.41×avg

Market Cap

1.70BUSD

P/E Ratio

-5.4TTM

Div Yield

-ann

Viridian Therapeutics, Inc.

VRDNNASDAQ Capital Market·USD·Closed

Viridian Therapeutics, Inc.

VRDNNASDAQ·USD·Closed

$18.92

−4.92%

$18.92

−$0.98 (4.92%)

52W Range

27thpctl

Volume

0.41×avg

Mkt Cap

1.70BUSD

P/E

-5.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings